Literature DB >> 3815587

DNA-binding products of nornitrogen mustard, a metabolite of cyclophosphamide.

K Hemminki.   

Abstract

Nornitrogen mustard was shown to bind to the N-7 position of guanine in DNA and guanosine. The initial binding product was NOR-G. N-(2-chloroethyl)-N-[2-(7-guaninyl)ethyl]amine but it was converted with time to a hydroxylated derivative. NOR-OH-G and to a cross-link, G-NOR-G. The NOR-OH-G adduct was also seen in the reactions of aziridineethanol. The cross-link appeared to depurinate slower than the two other adducts so that it was the main adduct after 72 h of incubation. The rate of reaction was higher at pH 6.0 than at pH 7.4 but even at pH 7.4 adducts were formed. When isolated NOR-G was incubated it was shown to be converted exclusively to NOR-OH-G at pH 5 but at pH 7.4 the main product was a dimer. The half-life of NOR-OH-G formation at pH 7.4 and 37 degrees C was 4 h. The mustard arms of NOR-G and NOR-OH-G had pKa values of about 7.5 and 10, respectively. This was probably related to the somewhat higher rate of imidazole ring-opening of NOR-OH-gua as compared to NOR-gua. The lability of the imidazole ring of the guanosine adducts of nornitrogen mustard is intermediate to those of phosphoramide mustard and nitrogen mustard.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3815587     DOI: 10.1016/0009-2797(87)90020-2

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  11 in total

1.  Covalent DNA-Protein Cross-Linking by Phosphoramide Mustard and Nornitrogen Mustard in Human Cells.

Authors:  Arnold Groehler; Peter W Villalta; Colin Campbell; Natalia Tretyakova
Journal:  Chem Res Toxicol       Date:  2016-01-20       Impact factor: 3.739

2.  Formation of cyclophosphamide specific DNA adducts in hematological diseases.

Authors:  L'Aurelle A Johnson; Bhaskar Malayappan; Natalia Tretyakova; Colin Campbell; Margaret L MacMillan; John E Wagner; Pamala A Jacobson
Journal:  Pediatr Blood Cancer       Date:  2011-07-25       Impact factor: 3.167

Review 3.  Mass Spectrometry-Based Tools to Characterize DNA-Protein Cross-Linking by Bis-Electrophiles.

Authors:  Arnold Groehler; Amanda Degner; Natalia Y Tretyakova
Journal:  Basic Clin Pharmacol Toxicol       Date:  2017-03-14       Impact factor: 4.080

4.  Characterization of nitrogen mustard formamidopyrimidine adduct formation of bis(2-chloroethyl)ethylamine with calf thymus DNA and a human mammary cancer cell line.

Authors:  Francesca Gruppi; Leila Hejazi; Plamen P Christov; Sesha Krishnamachari; Robert J Turesky; Carmelo J Rizzo
Journal:  Chem Res Toxicol       Date:  2015-09-01       Impact factor: 3.739

5.  Cytotoxicity, DNA cross-linking, and DNA single-strand breaks induced by cyclophosphamide in a rat leukemia in vivo.

Authors:  J Y Wang; G Prorok; W P Vaughan
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

6.  Kinetics of hydrolysis in vitro of nornitrogen mustard, a metabolite of phosphoramide mustard and cyclophosphamide.

Authors:  K Hemminki; A Alhonen; E Linkola; A Hesso
Journal:  Arch Toxicol       Date:  1987-12       Impact factor: 5.153

7.  Mutagenic potential of nitrogen mustard-induced formamidopyrimidine DNA adduct: Contribution of the non-canonical α-anomer.

Authors:  Irina G Minko; Carmelo J Rizzo; R Stephen Lloyd
Journal:  J Biol Chem       Date:  2017-09-28       Impact factor: 5.157

8.  Mutagenicity of a Model DNA-Peptide Cross-Link in Human Cells: Roles of Translesion Synthesis DNA Polymerases.

Authors:  Paritosh Pande; Shaofei Ji; Shivam Mukherjee; Orlando D Schärer; Natalia Y Tretyakova; Ashis K Basu
Journal:  Chem Res Toxicol       Date:  2016-12-21       Impact factor: 3.739

9.  Synthesis and characterization of oligonucleotides containing a nitrogen mustard formamidopyrimidine monoadduct of deoxyguanosine.

Authors:  Plamen P Christov; Kyu-Jun Son; Carmelo J Rizzo
Journal:  Chem Res Toxicol       Date:  2014-08-28       Impact factor: 3.739

Review 10.  DNA damage and repair in human cancer: molecular mechanisms and contribution to therapy-related leukemias.

Authors:  Ida Casorelli; Cecilia Bossa; Margherita Bignami
Journal:  Int J Environ Res Public Health       Date:  2012-07-27       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.